Atacicept, a fusion protein that inhibits both BAFF and anti-A proliferation-inducing ligand (APRIL), showed safety and efficacy in the treatment of flares in SLE (48), but has not been trialled in PID yet. This evidence concerns the gene TNFSF13B and systemic lupus erythematosus.